Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Yahoo! Finance]
Oruka Therapeutics, Inc. (ORKA)
Company Research
Source: Yahoo! Finance
Transaction summary Metric Value Shares sold (direct) Transaction value Post-transaction shares (direct) Post-transaction value (direct ownership) $2.19 million Transaction value based on SEC Form 4 weighted average purchase price ($66.12); post-transaction value based on April 15, 2026 market close ($66.12). Key questions What does the derivative context reveal about this transaction? This sale was linked to the exercise of 3,500 options, resulting in both the immediate conversion and disposition of shares, which is a common liquidity event for equity-compensated executives. How did the transaction impact Joana Goncalves's direct Common Stock ownership? The sale reduced her direct Common Stock holdings by 17.34%, from 40,377 to 33,377 shares, but left her with a substantial portfolio of unexercised options and warrants that can be converted to Common Stock in the future. Was the transaction routine or discretionary, and what governance applied? The tran
Show less
Read more
Impact Snapshot
Event Time:
ORKA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORKA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORKA alerts
High impacting Oruka Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ORKA
News
- Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Oruka Therapeutics price target raised to $85 from $45 at Wedbush [Yahoo! Finance]Yahoo! Finance
- Oruka Therapeutics (ORKA) had its price target raised by Wedbush from $45.00 to $85.00. They now have an "outperform" rating on the stock.MarketBeat
- Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by Guggenheim. They now have a $125.00 price target on the stock.MarketBeat
- Oruka Therapeutics (ORKA) had its price target raised by BTIG Research from $73.00 to $78.00. They now have a "buy" rating on the stock.MarketBeat
ORKA
Earnings
- 3/12/26 - Beat
ORKA
Sec Filings
- 4/21/26 - Form 424B7
- 4/17/26 - Form ARS
- 4/17/26 - Form DEFA14A
- ORKA's page on the SEC website